Celularity
CELU
40 hedge funds and large institutions have $2.45M invested in Celularity in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 39 → 40 (+1)
0.08% more ownership
Funds ownership: 7.55% → 7.63% (+0.08%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital inflows, than outflows
Capital inflows: $198K | Capital outflows: $200K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$95.1K |
| 2 |
HRT Financial
New York
|
+$42K |
| 3 |
Jane Street
New York
|
+$27.6K |
| 4 |
Virtu Financial
New York
|
+$17.9K |
| 5 |
IFP Advisors
Tampa,
Florida
|
+$3.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Valmark Advisers
Akron,
Ohio
|
-$66.5K |
| 2 |
BlackRock
New York
|
-$49.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$23K |
| 4 |
Two Sigma Securities
New York
|
-$19.8K |
| 5 |
XTX Topco
George Town,
Cayman Islands
|
-$17K |
CELU Hedge Fund Activity: Q2 2026 in Review
40 of the 8,380 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q2 2026, worth a combined $2.45M — down 16% from $2.89M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CELU positions and 4 closed out — a net gain of 1 holder — while 10 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $95.1K. The largest seller was Valmark Advisers, exiting entirely with an estimated $66.5K sold.
- 40 institutional investors held Celularity (CELU) as of Q2 2026, up from 39 in Q1 2026.
- Funds reported $2.45M of Celularity stock for Q2 2026, down 16% quarter-over-quarter.
- 5 funds opened new Celularity positions in Q2 2026 and 4 closed out, a net change of +1 holder.
- The largest Celularity buyer in Q2 2026 was Citadel Advisors, an estimated $95.1K added.
- The largest Celularity seller in Q2 2026 was Valmark Advisers, an estimated $66.5K sold.
Based on aggregated 13F filings for Q2 2026.